— Know what they know.
Not Investment Advice
Also trades as: 0IV3.L (LSE) · $vol 0M

GERN NASDAQ

Geron Corporation
1W: -7.3% 1M: -8.0% 3M: -17.9% YTD: -12.9% 1Y: -7.3% 3Y: -35.0% 5Y: -19.0%
$1.15
+0.00 (+0.00%)
Pre-Market: $1.16 (+0.01, +0.87%)
Weekly Expected Move ±5.4%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $738.8M mcap · 556M float · 1.88% daily turnover · Short 52% of daily vol
Credit Risk of going bust: higher than 60% of companies Debt: 14.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 98%), Geron Corporation would be worth roughly what it owes.
Total debt $122.1M against a stock market value of $738.8M.
Distance to default 4.22 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $60.1M (short-term plus half of long-term), stock volatility 62.8%; Altman Z'' -6.31. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$184M +138.8% ▲
5Y CAGR: +273.5%
Gross Profit
$179M +136.5% ▲
Operating Income
-$54M +69.0% ▲
Net Income
-$86M +50.9% ▲
EPS (Diluted)
$-0.13 +51.9% ▲
EBITDA
-$52M +66.5% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1M$596K$237K$77M$184M
YoY Growth+450.6%-57.2%-60.2%+32386.9%+138.8%
Cost of Revenue$0$0$0$1M$5M
Gross Profit$1M$596K$237K$76M$179M
Gross Margin100.0%100.0%100.0%98.4%97.4%
R&D Expenses$86M$96M$125M$104M$74M
SG&A Expenses$30M$44M$69M$146M$159M
Operating Expenses$115M$139M$194M$249M$233M
Operating Income-$114M-$139M-$194M-$174M-$54M
Operating Margin-8183.7%-23246.6%-81832.9%-225.6%-29.3%
Interest Expense$4M$7M$8M$19M$33M
Income Before Tax-$116M-$142M-$184M-$175M-$86M
Tax Expense$0$0$0$0$0
Net Income-$116M-$142M-$184M-$175M-$86M
Net Margin-8335.4%-23808.9%-77690.7%-226.7%-46.7%
EPS (Diluted)$-0.37$-0.37$-0.32$-0.27$-0.13
EBITDA-$112M-$134M-$175M-$155M-$52M
Shares Outstanding328M381M571M646M667M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms